SNORD35B: A Small Nucleolar RNA in Focus (G84546)

Target Name: SNORD35B

NCBI ID: G84546

SNORD35B

Other Name(s): small nucleolar RNA, C/D box 35B | Small nucleolar RNA, C/D box 35B | RNU35B | U35B

SNORD35B: A Small Nucleolar RNA in Focus

Small nucleolar RNA (snRNA) is a class of non-coding RNAs (ncRNAs) that play critical roles in various cellular processes, including chromatin regulation, gene expression, and RNA metabolism. One of the well-known snRNAs is SNORD35B, which is located within the C/D box region of chromosome 6 and has been shown to be involved in various cellular processes.

SNORD35B is a 24.8 kilobase (kb) long RNA molecule, and it is localized to the nuclear matrix, where it is involved in various cellular processes such as chromatin remodeling, histone modification, and non-coding RNA (ncRNA) regulation.

SNORD35B is a key regulator of chromatin remodeling and histone modification. It has been shown to interact with the protein component HIF1伪 and component ASF1, which are involved in the regulation of chromatin structure and gene expression.

In addition to its role in chromatin remodeling and histone modification, SNORD35B is also involved in the regulation of ncRNA expression. It has been shown to interact with the protein known as USP4, which is involved in the regulation of snRNA expression.

SNORD35B is also known as HAF-1a, which is a member of the HAF family of snRNAs. The HAF family is characterized by the presence of a specific domain called HAF-1伪, which is responsible for the regulation of snRNA expression and localization to specific cellular processes.

SNORD35B has been shown to play a critical role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. It has been shown to be involved in the regulation of various cellular signaling pathways, including the TGF-β pathway, the PI3K /Akt pathway, and the NF-kappa-B pathway.

SNORD35B is also a potential drug target and biomarker. Because it can interfere with cell apoptosis, it may be used as a target for anti-tumor drugs. Some studies have shown that inhibiting the expression level of SNORD35B can inhibit the growth and spread of tumor cells, which has positive significance for tumor treatment. In addition, the expression level of SNORD35B is also closely related to the prognosis of various cancers, such as lung cancer, liver cancer, and breast cancer.

In conclusion, SNORD35B is a small nucleolar RNA that plays critical roles in various cellular processes, including chromatin remodeling, histone modification, and ncRNA regulation. It is a potential drug target and biomarker and its regulation of cellular processes and its potential as a therapeutic target in various diseases is under further investigation.

SNORD35B is a small nucleolar RNA located within the C/D box region of chromosome 6 and is involved in various cellular processes such as chromatin remodeling, histone modification, and ncRNA regulation.

SNORD35B has been shown to interact with the protein HIF1伪 and ASF1, which are involved in the regulation of chromatin structure and gene expression.

SNORD35B has been shown to interact with the protein USP4, which is involved in the regulation of snRNA expression.

The HAF family of snRNAs is characterized by the presence of a specific domain called HAF-1伪, which is responsible for the regulation of snRNA expression and localization to specific cellular processes.

SNORD35B is involved in the regulation of various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway and the NF-kappa-B pathway.

SNORD35B is a potential drug target and biomarker and its regulation of cellular processes and its potential as a therapeutic target in various diseases is under further investigation.

Protein Name: Small Nucleolar RNA, C/D Box 35B

The "SNORD35B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD35B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets